Healthcare

The global dry eye disease market is witnessing significant growth owing to the rising prevalence of dry eye disease among people spending increased time staring at digital screens. Dry eye disease, also known as keratoconjunctivitis sicca, is a common ocular condition caused due to lack of tears or insufficient tear production by the lacrimal glands of the eyes. It occurs when the eyes do not produce enough tears or when the tears evaporates too quickly and do not lubricate the eyes properly. Some common symptoms of dry eye disease include irritation, burning sensation, dryness, redness, blurred vision, and eye fatigue.  The growing use of computers, smartphones, tablets and other digital devices has led to a substantial surge in the screen time spent by people at work and homes, which has significantly contributed to the development of dry eye symptoms. Prolonged screen time causes infrequent blinking due to staring at screens resulting in over-evaporation of tears and inflammation.

The global animal healthcare industry has seen significant growth in recent years due to rising pet ownership and increasing awareness regarding animal health. Animal healthcare products like vaccines, pharmaceuticals, feed additives and others help prevent widespread infections and ensure the overall well-being of pets and livestock. Vaccines help provide immunity against fatal diseases in animals. Pharmaceuticals like antibiotics, anthelmintics and anti-inflammatory drugs are used for treatment of various diseases and infections. Feed additives are increasingly used for improved growth performance, feed efficiency and preventing risk of diseases. The growing humanization of pets and their perception as companions rather than utility has boosted spending on animal health and wellness. Rising disposable incomes in developing countries allow owners to spend more on quality pet food and healthcare. Moreover, there has been a surge in livestock farming to meet the rising demand for meat a

Artificial kidneys, also known as bioartificial kidneys or kidney dialyzers, are artificially produced organs that fulfill the functions of natural kidneys by filtering waste and excess fluid from the blood. They are developed to provide an alternative to conventional kidney dialysis in treating kidney failure. The artificial kidney aims to mimic natural kidney functions through microfiltration membranes, blood vessels and other components. Growing technological advancements have significantly improved the safety and efficacy of these biomimicking kidneys. As conventional dialysis procedures are time-consuming and resource intensive, artificial kidneys offer significant advantages by filtering blood outside the body in a more convenient way. The global burden of chronic kidney disease continues to rise with aging populations and growth of non-communicable diseases such as diabetes. This has increased the demand for alternate treatment options for end stage renal disease patients.  The

Ambulatory surgical centers (ASCs) provide same-day surgical care, including diagnostic and preventive procedures. ASCs are modern medical facilities focused on performing surgical procedures that do not require an overnight hospital stay. Surgeries performed at ASCs include cataract removal, colonoscopy, endoscopic procedures, pain management, podiatric procedures, orthopedic procedures, and dental procedures. ASCs offer a lower-cost alternative to hospital outpatient departments for minor surgical procedures. Patients choosing ASCs over hospital outpatient departments experience reduced wait times and avoid risks of hospital-acquired infections. Additionally, payers such as private insurance companies and government programs prefer ASCs due to lower costs compared to hospital outpatient facilities.  The global Ambulatory Surgical Center Market is estimated to be valued at US$100.3 billion in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period 2024 to 2031, as high

Platelet rich plasma therapy is gaining popularity for various musculoskeletal applications such as orthopedic surgeries, knee osteoarthritis, and acute sports injuries. Platelet rich plasma contains growth factors that help in tissue regeneration and healing. It is produced from the patient's own blood through centrifugation process which separates and concentrates platelets from other blood components. This natural method aids in healing by stimulating cells and initiating wound healing cascade through release of growth factors from platelets. The injection of platelet rich plasma regulates cell differentiation and increases collagen matrix production to repair damaged tissues. It has shown efficacy in reducing inflammation and pain for various musculoskeletal disorders.  The global Platelet Rich Plasma Market is estimated to be valued at US$ 500.25 Mn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031, as highlighted in a new report published

The gene synthesis industry involves the artificial creation of genes and gene fragments using DNA which expands applications in biological research, genomic studies and pharmaceuticals. DNA is composed of four nucleotide bases of adenine, guanine, cytosine and thymine which make up the genetic code and determine the traits of living organisms. Using DNA synthesis technologies, genes and sections of DNA can be built up nucleotide by nucleotide to be as short as 50 base pairs or exceeding 5,000 base pairs with desired base pair sequences. The global gene synthesis market involves companies providing synthesized genes, gene libraries and gene fragments to support various applications. As a result of streamlined design and assembly techniques, synthesized genes are enabling easier cloning, pathway engineering and genome editing experiments underpinning advancements across molecular biology domains.  The global Gene Synthesis Market is estimated to be valued at US$ 5.2 billion in 2023 and

Digital pathology involves digitizing glass slides through high-resolution scanning and utilizing powerful algorithms for analysis and interpretation of tissue samples. This allows pathologists to observe tissue samples digitally on high-resolution screens instead of microscopes and share images across geographies for additional consultation, which allows for faster diagnosis. Digital pathology has several advantages over traditional microscopy as it enables pathologists to view and annotate multiple slides simultaneously, perform automatic image analysis, long-term archiving and easy retrieval of slides.  The global Digital Pathology Market is estimated to be valued at US$ 994.95 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.  Get more insights on this topic:  https://www.coherentmarketinsights.com/market-insight/digital-pathology-market-379 Market key trends:  One of the

The cosmeceuticals industry has experienced significant growth in the past decade owing to the increasing demand for anti-aging skincare products. Cosmeceuticals are cosmetic formulations that deliver biologically active skincare ingredients aimed at treating or preventing specific skin conditions. Anti-aging products have been the prime focus of cosmeceutical manufacturers as they constitute the largest segment within the market. Growing awareness about the benefits of ingredients such as peptides, retinol, hyaluronic acid, and vitamins A, C, and E in slowing down the signs of aging has led to higher adoption of anti-wrinkle creams, serums, and gels. Additionally, the busy lifestyles and high levels of stress have accelerated skin aging, prompting consumers to invest more in effective anti-aging solutions. The global Cosmeceuticals Market is estimated to be valued at US$ 83.9 in 2024 and is expected to exhibit a CAGR of 9.2% over the forecast period 2024 to 2031, as highlighted in a n

The demand for generic medicines has been rising constantly over the past few years owing to increasing healthcare costs and patent expirations of blockbuster drugs. Active pharmaceutical ingredients (APIs), which are the biologically active components in drugs, are the key ingredients in generic medicines. APIs provide the intended effects of pharmaceutical drug products. They are manufactured through chemical or biological synthesis. Some of the widely used APIs include acetaminophen, atorvastatin calcium, ibuprofen, and metformin hydrochloride. APIs are used to produce medications for treating various therapeutic conditions including cardiovascular diseases, pain management, diabetes, cancer, and neurological disorders.  The global Active Pharmaceutical Ingredients Market is estimated to be valued at US$ 249.3 Bn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Get more insi

Phenylketonuria (PKU) is an inherited disorder caused due to the body's inability to break down an amino acid called phenylalanine. This amino acid is commonly found in most foods. Phenylketonuria can cause intellectual disability or other neurological problems if not treated properly. Dietary enzymes, gene therapies and drug alternatives are commonly used to treat PKU by restricting phenylalanine intake. The global Phenylketonuria Treatment Market highly relies on dietary restriction and special formula foods that are low in phenylalanine. Patients afflicted by PKU are prescribed medical foods as substitutes for normal protein foods to prevent toxic buildup of phenylalanine in their bodies. Increased focus on screening programs for newborns and better diagnosis methods is boosting the demand for such customized foods and therapeutics.  The global Phenylketonuria Treatment Market is estimated to be valued at US$ 2.62 billion in 2023 and is expected to exhibit a CAGR of 8.6% over th

Opioids agonist drugs have gained substantial acceptance in managing chronic and acute pain conditions afflicting millions globally. These drugs mimick the effect of endogenous opioid peptides in modulating pain signal transmission along neural circuits. Key opioid agonist drugs such as morphine, oxycodone, hydrocodone, codeine, and fentanyl are extensively utilized owing to their high potency and duration of pain relief. Their mechanism of activating mu, delta, and kappa opioid receptors effectively counteracts nociceptive signaling at the spinal cord and brain level.  The global Opioids Agonist Drugs Market is estimated to be valued at US$ 32 Billion in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.  Get more insights on this topic:  https://www.coherentmarketinsights.com/market-insight/opioids-market-135 Market key trends: One of the major trends driving the opioids agonist d

Chronic Kidney Disease (CKD) refers to the gradual loss of kidney function over time. CKD drugs are used to treat various stages of CKD depending on the severity. Some of the common CKD drugs include angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), potassium binders, calcium supplements, and phosphate binders. The increasing prevalence of diabetes and hypertension are some of the major risk factors leading to the growing demand for CKD drugs globally. These conditions, if left untreated, can damage kidneys over time and eventually lead to kidney failure.  The global Chronic Kidney Disease Drugs Market is estimated to be valued at US$ 13,220.0 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Get more insights on this topic:  https://www.coherentmarketinsights.com/market-insight/chronic-kidney-disease-drugs-market-1713 Market key trends:

Protein A resin is the key chromatography material used in the production and purification of monoclonal antibodies. Monoclonal antibodies are extensively used drugs for conditions including cancer, autoimmune disorders, and other chronic ailments. Their demand has been rising at a steady pace owing to growing antibody drug approvals and market acceptance of targeted immunotherapies. Protein A resin is immobilized on cross-linked agarose beads and selectively binds immunoglobulin G (IgG) antibodies from complex biological samples. Some key advantages include high specificity for IgG and batch-to-batch consistency to efficiently and cost-effectively purify and isolate monoclonal antibodies on an industrial scale. The global Protein A Resin Market is estimated to be valued at US$ 474.0 Mn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Get more insights on this topic:  https://w

Nanorobotics involves the development of robots tiny enough to interact with individual cells and biomolecular systems. These tiny robots called nanobots can be deployed for various medical applications such as targeted drug delivery, biomolecular manipulation, and microsurgery at high precision. By incorporating advances in nanotechnology and miniaturization, nanorobots can perform delicate medical procedures and minimize invasive surgeries leading to improved patient outcomes. The global Nanorobotics Market is estimated to be valued at US$ 989.7 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.  Nanorobotics has the potential to revolutionize medical diagnostics and treatment. Nanobots can be programmed to travel inside the human body to identify cancer cells, perform precise surgeries, and release pharmaceutical drugs only in affected areas with minimal side effects. This

The marine biotechnology industry involves the utilization of marine resources for developing pharmaceuticals, nutraceuticals, biofuels and other biological products. Ocean covers over 70% of the Earth's surface and contains resources such as enzymes, proteins, omega-3 fatty acids etc. that can be used to develop products for various industries including pharmaceutical, cosmetic, food etc. Marine organisms such as sponges, corals, algae, microbes and other organisms have adapted to survive in extreme ocean conditions and produce unique biomolecules.  Marine resources offer immense potential for novel chemical compounds that could be developed into drugs for treatments of cancer, diabetes, cardiovascular diseases etc. For example, omega-3 fatty acids from fish oil have shown therapeutic effects in reducing the risk of heart diseases. Marine biotechnology also helps in environmental monitoring and offers sustainable solutions by developing products from marine wastes. The global Mari

Diabetes is a chronic metabolic disorder that damages nerves and reduces blood circulation, thereby raising the risks of foot ulcers. Diabetic foot ulcers are chronic wounds that develop primarily in patients suffering from diabetes as a result of prolonged high blood sugar levels. If left untreated, these ulcers can become severely infected and may ultimately lead to lower leg amputation. Products used in treating diabetic foot ulcers include wound care dressings, growth factors, skin grafts, and negative pressure wound therapy devices. Wound care dressings help manage exudate levels and maintain a moist wound healing environment. Growth factors accelerate the healing process by stimulating cell growth and division. Skin grafts are used when ulcers become deep and do not heal on their own through standard treatments over a long period. Negative pressure wound therapy uses sub-atmospheric pressure to stimulate blood flow and promote granulation tissue formation. The rising prevalence o

Cardiac surgery instruments such as clamps and forceps are used to repair diseased or damaged heart valves, correct congenital heart defects and perform bypass surgery. These instruments allow surgeons to delicately handle tissues and vessels with precision. The demand for cardiac surgery is increasing globally owing to rising prevalence of cardiovascular diseases. Additionally, the increasing adoption of minimally invasive techniques over traditional open-heart surgeries is propelling the cardiac surgery instruments market growth. Minimally invasive cardiac surgery causes less pain, fewer complications and faster recovery time compared to traditional surgeries. The global cardiac surgery instrument market is estimated to be valued at US$ 2.5 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Get more insights on this topic:  https://www.coherentmarketinsights.com/market-

Antimicrobial therapeutics are medicinal products including antibiotics, antivirals, antifungals, and antiparasitics that are used to treat and prevent microbial infections. Antimicrobial therapeutics play a pivotal role in the management of various infectious diseases by either killing pathogens or suppressing their growth. The global antimicrobial resistance poses a serious threat to public health and the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, viruses, fungi, and parasites has become crucial, fueling investments in antimicrobial R&D.  The global Antimicrobial Therapeutics Market is estimated to be valued at US$155.5 billion in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Get more insights on this topic:  https://www.coherentmarketinsights.com/market-insight/antimicrobial-therapeutics-market-5845 Market key trends: